China pharma firms turn to local reagent suppliers to cut costs


The rush to use domestically made reagents has accelerated since April. — Reuters

PHARMACEUTICAL research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers say, as they seek to cut costs and delivery times.

Western reagent suppliers including US-based Thermo Fisher Scientific and Germany’s Merck have profited in the world’s second-largest pharmaceutical market from the compounds used in lab tests for analysis and quality control.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Insight

How the Iran war could split the AI boom in two
A century of planters: Learning and the next season
Digital tax incentives
Trump’s Iran war oil shield is cracking
Countries tripping over US tariffs
Crude oil’s Catch-22
Prolonged oil shocks – Options, policy response
A tale of overvaluations and bottom dwellers
Leading with respectful fear
Addressing Pos Malaysia’s conundrums

Others Also Read